Literature DB >> 1738097

H+ coupled active transport of bestatin via the dipeptide transport system in rabbit intestinal brush-border membranes.

K Inui1, Y Tomita, T Katsura, T Okano, M Takano, R Hori.   

Abstract

Bestatin [(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl-L-leucine], a dipeptide containing an unusual amino acid, has been used clinically as an anticancer agent in p.o. dosage form. We examined the transport characteristics of [3H]bestatin by rabbit intestinal brush-border membrane vesicles. Bestatin uptake was stimulated by an inward H+ gradient (overshoot phenomenon) and by an interior-negative membrane potential. About half of the apparent bestatin uptake at 1 mM by brush-border membrane vesicles was estimated as binding to the membranes. The affinity constant for the bestatin transport was 0.52 mM. The uptake of bestatin by brush-border membrane vesicles was inhibited by p.o. cephalosporins and dipeptides, but not by amino acids. In vesicles preloaded with either bestatin, cephradine or glycylsarcosine, the uptake of [3H]bestatin was stimulated markedly (countertransport effect). These results indicate that bestatin is transported via the H+/dipeptide transport system in rabbit intestinal brush-border membranes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738097

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

Review 1.  Intestinal peptide transport systems and oral drug availability.

Authors:  C Y Yang; A H Dantzig; C Pidgeon
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

2.  Kyotorphin transport and metabolism in rat and mouse neonatal astrocytes.

Authors:  Jianming Xiang; Huidi Jiang; Yongjun Hu; David E Smith; Richard F Keep
Journal:  Brain Res       Date:  2010-06-09       Impact factor: 3.252

Review 3.  Theoretical predictions of drug absorption in drug discovery and development.

Authors:  Patric Stenberg; Christel A S Bergström; Kristina Luthman; Per Artursson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1.

Authors:  Monica Sala-Rabanal; Donald D F Loo; Bruce A Hirayama; Eric Turk; Ernest M Wright
Journal:  J Physiol       Date:  2006-04-20       Impact factor: 5.182

5.  Localization of peptide transporter in nuclei and lysosomes of the pancreas.

Authors:  D E Bockman; V Ganapathy; T G Oblak; F H Leibach
Journal:  Int J Pancreatol       Date:  1997-12

6.  AtOPT3, a member of the oligopeptide transporter family, is essential for embryo development in Arabidopsis.

Authors:  Minviluz G Stacey; Serry Koh; Jeffrey Becker; Gary Stacey
Journal:  Plant Cell       Date:  2002-11       Impact factor: 11.277

7.  Population pharmacokinetic modeling of cefadroxil renal transport in wild-type and Pept2 knockout mice.

Authors:  Yehua Xie; Hong Shen; Yongjun Hu; Meihua Rose Feng; David E Smith
Journal:  Xenobiotica       Date:  2015-09-15       Impact factor: 1.908

Review 8.  Oral Contraceptives after Bariatric Surgery.

Authors:  Joël Schlatter
Journal:  Obes Facts       Date:  2017-04-22       Impact factor: 3.942

9.  A fluorescent hPept1 transporter substrate for uptake screening.

Authors:  Christopher P Landowski; Hyo-kyung Han; Kyung-Dall Lee; Gordon L Amidon
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

10.  Expression and protein kinase C-dependent regulation of peptide/H+ co-transport system in the Caco-2 human colon carcinoma cell line.

Authors:  M Brandsch; Y Miyamoto; V Ganapathy; F H Leibach
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.